ROS Can Shorten or Lengthen Life

Reactive oxygen species have opposing effects on roundworm longevity depending on whether these molecules are in the mitochondria or the cytoplasm.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, HEITI PAVESThe role of reactive oxygen species (ROS) on life span just got more complicated than previously thought. Scientists had already found evidence that the effects of ROS in mitochondria can be life span-extending or life span-shrinking, depending on ROS levels. Now, researchers show in PLOS Genetics this week (February 11) that ROS can also act in opposing ways depending on cellular location. In particular, upping ROS quantities in mitochondria of C. elegans increased the roundworms’ life spans, while in the cytoplasm this had the opposite effect.

Jeremy Van Raamsdonk of the Van Andel Research Institute’s Laboratory of Aging and Neurodegenerative Disease in Grand Rapids, Michigan, and his colleagues looked at the effect of ROS in different cellular compartments by selectively eliminating a C. elegans antioxidant gene in either mitochondria or cytoplasm, thereby boosting ROS levels.

“ROS are neither good nor bad. They have functional roles in the cell and it appears that it is crucial to have the right levels of ROS in the right location,” Van Raamsdonk said in a press release. “This means that treatments with antioxidants may need to be targeted to maximize beneficial effects and minimize possible detrimental effects.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies